Accessibility Menu
 
Amplify ETF Trust - Amplify Weight Loss Drug & Treatment ETF logo

Amplify ETF Trust - Amplify Weight Loss Drug & Treatment ETF

(NYSEMKT) THNR

Current Price$23.91
Market CapN/A
Since IPO (2024)-3%
5 YearN/A
1 Year+14%
1 Month+1%

Amplify ETF Trust - Amplify Weight Loss Drug & Treatment ETF Financials at a Glance

Market Cap

N/A

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.41

Beta (Volatility)

0.00 (Low)

Price

$23.91

Volume

5,940.074

Open

$24.08

Previous Close

$23.91

Daily Range

$23.91 - $24.08

52-Week Range

$20.98 - $27.28

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Amplify ETF Trust - Amplify Weight Loss Drug & Treatment ETF

Industry

Capital Markets

Headquarters

Lisle, IL 60532, US

THNR Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

$0.00

Shares Outstanding

170.00K

Volume

5.94K

Avg. Volume

0

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Amplify ETF Trust - Amplify Weight Loss Drug & Treatment ETF Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

$0.00

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Net Cash

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
EATZAdvisorShares Restaurant ETF
$26.85-0.92%
KPROKraneShares 100% KWEB Defined Outcome January 2027 ETF
$27.23-0.16%
CDIGCity Different Investments Global Equity ETF
$26.62-1.11%
IONProShares - S&P Global Core Battery Metals ETF
$63.14-1.36%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOFISoFi Technologies
$18.36-0.02%
NOKNokia
$11.30+0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$60.74-0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.14-0.01%

Questions About THNR

What is the current price of Amplify ETF Trust - Amplify Weight Loss Drug & Treatment ETF?

Amplify ETF Trust - Amplify Weight Loss Drug & Treatment ETF is trading at $23.91 per share.

What is the 52-week range for Amplify ETF Trust - Amplify Weight Loss Drug & Treatment ETF?

Over the past 52 weeks, Amplify ETF Trust - Amplify Weight Loss Drug & Treatment ETF has traded between $20.98 and $27.28.

How much debt does Amplify ETF Trust - Amplify Weight Loss Drug & Treatment ETF have?

Amplify ETF Trust - Amplify Weight Loss Drug & Treatment ETF total debt is unavailable.

How much cash does Amplify ETF Trust - Amplify Weight Loss Drug & Treatment ETF have on hand?

Amplify ETF Trust - Amplify Weight Loss Drug & Treatment ETF does not have cash on hand data available.

What is Amplify ETF Trust - Amplify Weight Loss Drug & Treatment ETF’s dividend yield?

Amplify ETF Trust - Amplify Weight Loss Drug & Treatment ETF does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.